Mr. Higgins of New York (for himself, Mr. Guthrie, Ms. Matsui, Mr. Bilirakis, Mr. Kilmer, Mr. Fitzpatrick, Mr. King of New York, Mr. Nadler, Mr. DeFazio, Mr. Hastings, Mr. Olson, Ms. Wasserman Schultz, Mr. Hurd of Texas, Mr. Bera, Mr. Cole, Mr. Khanna, Mr. McCaul, and Ms. Norton) introduced the following bill; which was referred to the Committee on Energy and Commerce
To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider.
Brett Guthrie
(KY); Doris O. Matsui
(CA); Gus M. Bilirakis
(FL); Derek Kilmer
(WA); Brian K. Fitzpatrick
(PA); Peter T. King
(NY); Jerrold Nadler
(NY); Peter A. DeFazio
(OR); Alcee L. Hastings
(FL); Pete Olson
(TX); Debbie Wasserman Schultz
(FL); Will Hurd
(TX); Ami Bera
(CA); Tom Cole
(OK); Ro Khanna
(CA); Michael T. McCaul
(TX); Eleanor Holmes Norton
(DC)
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Cancer Drug Parity Act of 2019. H.R. 1730. 116th
Cong., 1st
sess., Introduced in House March 13, 2019. https://www.govinfo.gov/app/details/BILLS-116hr1730ih.
APA
Congress, House of Representatives (2019, March 13). Cancer Drug Parity Act of 2019 (H.R. 1730 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116hr1730ih.
MLA
United States, Congress, House of Representatives. Cancer Drug Parity Act of 2019. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116hr1730ih. 116th Congress, H.R. 1730, Introduced in House 13 Mar. 2019.
Bluebook
H.R.1730 - 116th Congress (2019-2020): Cancer Drug Parity Act of 2019, H.R.1730, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116hr1730ih.
